Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BIO-TECHNE (TECH) Cash from Investing Activities: 2009-2025

Historic Cash from Investing Activities for BIO-TECHNE (TECH) over the last 16 years, with Sep 2025 value amounting to $605,000.

  • BIO-TECHNE's Cash from Investing Activities rose 102.79% to $605,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$12.9 million, marking a year-over-year increase of 81.74%. This contributed to the annual value of -$35.2 million for FY2025, which is 82.67% up from last year.
  • Per BIO-TECHNE's latest filing, its Cash from Investing Activities stood at $605,000 for Q3 2025, which was up 49.01% from $406,000 recorded in Q2 2025.
  • In the past 5 years, BIO-TECHNE's Cash from Investing Activities ranged from a high of $605,000 in Q3 2025 and a low of -$241.1 million during Q1 2023.
  • For the 3-year period, BIO-TECHNE's Cash from Investing Activities averaged around -$44.0 million, with its median value being -$8.9 million (2025).
  • In the last 5 years, BIO-TECHNE's Cash from Investing Activities plummeted by 28,001.55% in 2022 and then spiked by 104.61% in 2025.
  • Over the past 5 years, BIO-TECHNE's Cash from Investing Activities (Quarterly) stood at -$35.2 million in 2021, then soared by 99.69% to -$109,000 in 2022, then crashed by 21,616.51% to -$23.7 million in 2023, then soared by 78.74% to -$5.0 million in 2024, then skyrocketed by 102.79% to $605,000 in 2025.
  • Its Cash from Investing Activities stands at $605,000 for Q3 2025, versus $406,000 for Q2 2025 and -$8.9 million for Q1 2025.